Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Facilitator Version Module #12 Acute Kidney Injury created by Dr. Sepehr Khashaei, 09/2013 Objectives: 1. 2. 3. 4. 5. Define acute kidney injury (AKI) Identify the main types of AKI. Know the causes of AKI under each main category of AKI. Identify and understand the typical laboratory tests used in working up AKI. Understand the indications for initiating hemodialysis in kidney patients. References: 1) www.uptodate.com “Definition of acute kidney injury (acute renal failure)” 2) www.uptodate.com “Indications for initiation of dialysis in chronic kidney disease” 3) MKSAP 16, Nephrology section. 4) www.uptodate.com “Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)” 1) 4.Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204. Case: A 57-year old male with previous history of hypertension, DM type II, hyperlipidemia, and osteoarthritis of the knees presents to the Emergency Room with complaint of 2 days increasing fatigue, dizziness, and just not feeling good. His current medications are amlodipine, aspirin (81mg), lisinopril, hydrochlorothiazide, ibuprofen and atorvastatin. On physical examination, temperature is 37.2 ⁰C (99 ⁰F), heart rate is 75 beats/min, blood pressure is 92/53 mmHg, respiratory rate is 12/min and oxygen saturation is 96% on room air. He seems to be in no distress as he is lying in bed. He is positive for orthostasis on his orthostatic blood pressure and pulse measurements. The rest of the exam is normal. On the laboratory exam today, his creatinine is noted to be 3.4 with the creatinine of 1.1 notes 1 month ago in the clinic. What is the definition for AKI? The most accepted definition is the RIFLE criteria, which consists of three graded levels of injury (Risk, Injury, and Failure). The RIFLE strata are as follows: ■Risk — 1.5-fold increase in the serum creatinine or GFR decrease by 25 percent or urine output <0.5 mL/kg per hour for six hours ■Injury — Twofold increase in the serum creatinine or GFR decrease by 50 percent or urine output <0.5 mL/kg per hour for 12 hours ■Failure — Threefold increase in the serum creatinine or GFR decrease by 75 percent or urine output of <0.3 mL/kg per hour for 24 hours, or anuria for 12 hours ■Loss — Complete loss of kidney function (e.g., need for renal replacement therapy) for more than four weeks ■ESRD — Complete loss of kidney function (e.g., need for renal replacement therapy) for more than three months Does this patient have AKI? Yes, this patient has AKI and falls in the “failure” category. What are the risk factors for AKI? • • • • • • • Advanced Age Preexisting renal disease Diabetes Cardiac disease Liver disease Use of nephrotoxic drugs Surgery (especially associated with hypotension or hypoperfusion) What are the risk factors for AKI in this patient? DM, hypotension associated with orthostasis, and use of lisinorpil and ibuprofen (and possibly aspirin, although most do not consider 81mg aspirin as being nephrotoxic). What are the three main categories of AKI? • • • Pre-renal (most common outpatient cause) Post-renal Intra-renal (or intrinsic) Of the above categories, which one(s) are the more likely cause for this patient’s AKI given the information on the case so far? Pre-renal from volume depletion (diuretics) or intra-renal (low bp, lisinopril and ibuprofen use). What are the three main categories of intra-renal (intrinsic) AKI? • • • Acute tubular necrosis (ATN). Most common (75% of intrarenal causes of AKI). Glomerular damage (such as acute glomerular nephritides). This accounts for about 1% of all causes of AKI. Acute interstitial nephritis (AIN). This accounts for about 10-15% of all causes of AKI. Notes: • The two most common causes of AKI are pre-renal azotemia (good prognosis) and ATN (poorer prognosis). If this patient’s AKI was caused by an intra-renal etiology, which of the three categories of intra-renal causes would be more likely to be the cause of his AKI? ATN due to hypotension and concomitant use of lisinopril and ibuprofen (and possibly aspirin). What is the definition of oliguria and anuria? • • Oliguria is defined as <400 mL/day of urine output Anuria is defined as <50 mL/day of urine output What are the causes of prerenal AKI? • • • • • volume depletion/blood loss Renal artery stenosis or thrombosis or emboli or dissection CHF Cirrhosis Nephrotic syndrome • • Drugs (Diuretics, NSAIDS/Cox-2 inhibitors, ACEI/ARB, and in transplant patients interleukin-2, cyclosporine and tacrolimus) “Hepatorenal syndrome” What are the usual laboratory findings associated with pre-renal AKI? • • • • • • % FENa = (UNa/PNa)(PCr/UCr)(100%) and is <1% in pre-renal AKI. Can be >1% if patient is on a diuretic. BUN/Cr ration is usually high (> 20). Urine is very concentrated with urine osmolality often > Urine Na is usually < 20 (can be >20 if patient is on a diuretic) Urine specific gravity > 1.020 Urine sediment is usually bland but can show granular or hyaline casts. Note: Fractional excretion of sodium is the best test in assessing AKI • FENa percent = (UNa/PNa)(PCr/UCr)(100) • If <1%, likely pre-renal or acute glomerulonephritis (much less likely) • If >2%, likely not pre-renal • If 1-2%, think more likely not pre-renal although this is a gray zone • If patient has used diuretic in the last 24 hours, then use fractional excretion of urea (FEUrea) in place of FENa and substitute Urea or Na in the equation above. For FEUrea: • If <35%, likely pre-renal or acute glumerulonepritis (much less likely) • If >50%, likely on pre-renal • If 35-50%, think more likely not pre-renal, although this is a gray zone What are the causes of post-renal AKI? • • Anatomic urinary obstruction: – Bladder outlet obstruction (most common) – Bilateral ureteral outlet obstruction (much less likely) Intra-tubular obstruction (also thought of as an intra-renal problem in some textbooks). How do you diagnose post-renal AKI? • • • Ultrasound (the best method) CT scan Post-void bladder residual (for diagnosis of bladder outlet obstruction) What are the two major categories as causes of ATN? 1) Renal hypotension or transient ischemia to the kidney such as: – Surgery (most common) – Trauma – Burns – Sepsis – Cardiogenic 2) Toxic insult to the kidney (dose dependent) – Myoglobinuria (rhabdomyolysis) – Hemoglobinuria (hemolysis) – Heavy metals – Contrast dye – Drugs (aminoglycosides, amphotericin B, Cisplatin, foscarnet, pentamidine, IVIG). For the patient in our case study, if ATN was from AKI, which of the two mechanisms mentioned above, seem to be more likely responsible for the AKI? Renal hypotension causing ischemia to the kidney. What are the laboratory findings in ATN? • • • • • Urine is iso-osmolar (Osmolality <450 in almost all cases and usually <350) Urine specific gravity is ≈ 1.010 Urine Na is >20 (often >40) FENa >1%, usually >2% Urine sediment: large muddy brown granular casts The patient is admitted to the hospital and is started on intravenous fluids. Laboratory workup shows: Normal CBC. Sodium is 142, potassium 5.3, BUN 65, creatinine 3.4. The rest of metabolic panel as well as LFT’s are normal. As mentioned before his creatinine 1 month ago in the clinic was 1.1. Urinalysis is negative for protein, RBCs, and WBC’s. Urine specific gravity is 1.025. CXR is negative. Given these values, what is the most likely cause of AKI? Pre-renal due to volume depletion (BUN/Creatinine of >20 and urine specific gravity of 1.025). The ibuprofen, lisinopril, aspirin, amlodipine, and hydrochlorothiazide were held on admission. Continue asa if used for secondary prevention. The patient is given intravenous fluids and over the next 3 days, his creatinine improves and stays around 2.1 with BUN improving to 28. What would you do next? AKI has improved but has not resolved completely with intravenous fluids, indicating there is likely an additional cause for AKI. The most likely possibility in this case is AKI due to prolonged hypotension from volume depletion and the use of anti-hypertensives. Further work up: • • • FENA Renal ultrasound Check post void bladder residual. • • • Careful measurements of ins and outs and daily weights. Check urine sediments for any casts. Recheck urinalysis. The renal ultrasound is normal. The post void bladder residual is 15cc’s. The urinalysis is normal except for mild protein picked up by dipstick. The urine sediment shows muddy-brown casts. What is your diagnosis for patient’s AKI now? Initial pre-renal AKI now with ATN, likely due to hypotension and concomitant use of lisinopril and ibuprofen. On further questioning, the patient stated that 2 days prior to admission, he spent a lot of time in the extreme heat outside doing yard work and did not drink enough fluids except for 8 beers that day. He states that he does not drink alcohol on chronic basis. You suspect rhabdomyolysis as a contributing factor to his AKI and measure CPK level which is at 780. You suspect that this number was much higher three days ago when patient presented to the Emergency Room. You also suspect that rhabdomyolysis may have contributed to the patient’s AKI by further contributing to an ATN picture. What are the main measures and treatments for ATN? • • • • • • • Treat the precipitating cause Stop the offending drug or toxin. Prevent further ischemic insult to the kidney Equilibrate input and output to maintain euvolemia (trial of IVFs) Treat the hyperkalemia Nutrition support (which decreases catabolism) May need hemodialysis. The patient is placed on strict input and output measurements as well as daily weights and is kept euvolemic. All nephrotoxic medications were held on admission. His amlodipine was restarted once his blood pressure improved to try to keep his blood pressure in the 120-140 systolic range. The patient is now making about 1.2 liters of urine a day and his BUN and creatinine remain in the range of 28 and 2.1 respectively for the next four days. In respect to his prognosis in regards to recovery from his AKI and outpatient treatment, what would you tell the patient prior to discharge? The patient has somewhat better prognosis since his ATN is non-oliguric. If his creatinine does not improve within the next two weeks, he has a 10% chance of completely recovering his kidney function. If his kidney function has not improved by 5 weeks, he has only a 1% chance of recovering his kidney function. Other instructions at discharge: 1) keep his blood pressure in the 120-140 systolic range, 2) low salt diet, drink adequate amount of fluid, 3) avoid ibuprofen (or any other NSAIDS), hydrochlorothiazide, or lisinopril (discuss with nephrologist). What are the tree findings that when present should make one suspect AIN as etiology of AKI? • • • Fever Eosinophilia Rash (not common) What are the typical findings in the urine and urine sediment in patients with AIN? • • • • • Mild proteinuria (< 1gm/24hrs) Eosinophils (Hansel’s stain; has only 40% sensitivity and 72% specificity) RBCs WBCs without bacteria (sterile pyuria) WBC casts What are some of the most common drugs that cause AIN? • • • • • • • Antibiotics (especially beta-lactams, TMP/SMX, Rifampin, ciprofloxacin) NSAIDS (differs from other forms of AIN in that time of onset is longer (3-6 months), unlikely to have rash, fever, or peripheral eosinophilia, and recovery period much longer). Cimetidine Thiazides Phenytoin Allopurinol PPI’s Some other causes of AIN: • Sarcoidosis • SLE/immune medicated • Infection (pyelonephritis) • Transplant rejection • Idiopathic What are some general measures and treatment of all patients with AKI? • • • • • • • Hold nephrotoxic drugs and NSAIDS. Hold ACEI/ARB. Avoid contrast studies in patients with borderline or poor renal function. Recognize the problem as early as possible and stop the insult (drug, ischemia, hypovolemia, infection). Measure input and output (and daily weights if needed) and achieve euvolemia whenever possible. Manage electrolyte abnormalities. Adjust the dose of all medications that are renally cleared. In general what are some of the initial labs/tests that you would “think of ordering” in patients with AKI? • • • • • • • • • • • FENa (urine and serum sodium and creatinine) or FEUrea (urine and serum urea) Urine osmolality Urinalysis Chem 7 and CBC Post-void bladder residual Urine sediment (needs microscopic evaluation) Renal/bladder US or CT Urine eosinophils (Hansel’s stain) Spot urine protein/creatinine and/or 24 hour urine protein CPK Measure Ins and outs and daily weights When would you have considered this patient for acute dialysis? – Severe acidosis not responsive to other treatment – Severe electrolyte abnormalities, particularly elevated potassium with cardiac conduction effects – Severe fluid overload unresponsive to diuresis – Uremia with end-organ effects such as pericardial rubs MKSAP 16 Questions: • Nephrology Question 4. Answer B. • Nephrology Question 15. Answer A. • Nephrology Question 63. Answer D. • Nephrology Question 67. Answer D. • Nephrology Question 77. Answer A. • Nephrology Question 106. Answer C. Appendix 1 Some notes about pre-renal azotemia: • Pre-renal azotemia is often reversible within 24-48° and thus represents a low level of acute kidney injury. Once sufficient or sustained injury occurs, many patients progress to develop ATN. • A low FENa or FEUrea can also be seen in acute glomerulonephritis, vasculitis and obstruction. Glomerulonephritis and vasculitis affecting the kidneys are associated with the following findings in the urine (which differentiates them from pre-renal azotemia): – RBC casts – RBCs – Dysmorphic RBCs – Proteinuria (could be mild or heavy) Some notes about anatomic urinary obstruction: • Is the cause of 5% of all cases of AKI. • When diagnosed and corrected within 1 week of onset, prognosis and recovery is excellent. • If obstruction persists > 12 weeks, irreversible interstitial fibrosis and tubular atrophy can occur. • Presentation may alternate from anuria with complete obstruction to polyuria alternating with oliguria in partial obstruction. • Hyperkalemic renal tubular acidosis (RTA) is common. • Recovery occurs over 1-2 weeks after resolution of obstruction. • Tubular injury and solute retention may result in post-obstructive diuresis. • Post-obstructive diuresis may result in volume depletion and significant electrolyte loss. Treatment consists of matching urinary losses with intake (usually by intravenous fluids) and replenishing the electrolytes (may frequently need intravenous replacement). Some notes about intra-tubular obstruction: • Certain drugs/compounds can precipitate in the tubules to form obstructing crystals: – Methotrexate – Intravenous acyclovir – Sulfa antibiotics – Indinavir – Hypercalcemia – Ethylene glycol toxicity ~ Calcium oxalate crystals – Urate crystal nephropathy – after cancer chemotherapy induction in patients with highly proliferative tumors – Myeloma Cast Nephropathy: Light chains in Multiple Myeloma (remember the Tamm-Horsfall protein) Note: In post-renal AKI, the BUN/Cr ratio is elevated and serum potassium may be elevated due to associated Type 4 RTA. Some notes about ATN Hint #1: In ATN the plasma creatinine concentration tends to rise progressively and usually at a rate greater than 0.3-0.5 per day. In comparison, a slower rate of rise with periodic downward fluctuations (due to variations in renal perfusion) is suggestive of prerenal disease. Hint #2: Patients with pre-renal disease generally have a urine creatinine to plasma creatinine ratio >40 whereas in ATN this ratio is usually <20. Note: None of the criteria for diagnosis of pre-renal disease may be present in a patient with underlying renal disease. In this setting, the ability to concentrate urine and conserve sodium is often impaired and the urinalysis may be abnormal, reflecting the primary disorder. As a result, a cautious trial of fluids may be given (independent of urinary findings) if it is suspected that an acute rise in the plasma creatinine concentration may be due to volume depletion. Some other notes about ATN: • Even with dialysis, ½ of surgical patients and 1/3 of medical patients die. • For those who improve, 90% do so within 3 weeks and 99% within 6 weeks. • 25% of cases are non-oliguric. Some notes about AIN: • Fever, rash, and eosinophilia all together present in less than 10% of patients but each alone occur in about 30% of patients. • AIN may occur after 7-10 days of drug exposure; however, prior exposure to a drug may result in a more sudden onset. • Oliguria occurs in <20% cases. • May see increased cortical echogenicity on ultrasound. • Renal biopsy is the gold standard for dx. • Usually reversible if detected early, and offending drug promptly discontinued (i.e. within 1 week). • Biphasic recovery with early rapid recovery (6-8 weeks) followed by a longer more gradual recovery phase (1 year). Some notes about indications for dialysis: Relative indications for dialysis in CKD patients — Since an important goal of dialysis is to enhance the quality of life as well as to prolong survival, it is therefore important to consider less acute indications for dialysis such as anorexia and nausea, impaired nutritional status, increased sleepiness, and decreased energy level, attentiveness, and cognitive tasking. One needs to consider that the symptoms described here could also be due to medications that the patient is taking. Note: Dialysis has shown to improve albumin, prealbumin, nutritional status, and appetite in patients with ESRD. • Major abdominal surgery is a relative contraindication to peritoneal dialysis. • There is no particular advantage to utilizing hemodialysis versus peritoneal dialysis in eligible patients who require pre-transplant dialysis. • Post-transplant outcomes appear to be worse with a longer duration of dialysis before transplant occurs. Post Module Evaluation Please place completed evaluation in an interdepartmental mail envelope and address to Dr. Wendy Gerstein, Department of Medicine, VAMC (111) or give to Dr. Patrick Rendon at UNM Hospital. 1) Topic of module:__________________________ 2) On a scale of 1-5, how effective was this module for learning this topic? _________ (1= not effective at all, 5 = extremely effective) 3) Were there any obvious errors, confusing data, or omissions? Please list/comment below: ________________________________________________________________________ ________________________________________________________________________ ________________________________________________________________________ ________________________________________________________________________ 4) Was the attending involved in the teaching of this module? Yes/no (please circle). 5) Please provide any further comments/feedback about this module, or the inpatient curriculum in general: ________________________________________________________________________ ________________________________________________________________________ ________________________________________________________________________ ________________________________________________________________________ 6) Please circle one: Attending Resident (R2/R3) Intern Medical student